Touyun Biotech Group Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was HKD 198.07 million compared to HKD 72.95 million a year ago. Basic loss per share from continuing operations was HKD 0.0706 compared to HKD 0.0261 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 HKD | -4.17% | +15.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 82.44M | |
+21.35% | 21.97B | |
+8.34% | 17.64B | |
-12.49% | 9.62B | |
+19.15% | 9.29B | |
+3.78% | 5.01B | |
-13.09% | 4.62B | |
+12.87% | 2.98B | |
-5.60% | 2.96B | |
+13.27% | 2.78B |
- Stock Market
- Equities
- 1332 Stock
- News Touyun Biotech Group Limited
- Touyun Biotech Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022